An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.

NCT02350816 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped Completion of follow-up period

Conditions

Sanfilippo Syndrome
Mucopolysaccharidosis (MPS)

Interventions

DRUG: HGT-1410

Sponsor

Shire